Global Drug Discovery Technologies 麻豆原创 Research Report 2024

Publication ID:

PB501245728

Publication Date:

January 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

This report mainly focuses on drug discovery technologies marekt. Current drug discovery technologies aims to discover all the modern techniques and technologies used in drug discovery.
The global Drug Discovery Technologies market was valued at US$ 48000 million in 2023 and is anticipated to reach US$ 76370 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.
Regionally, North America will dominate the global drug discovery technologies market in 2022. Countries such as the United States lead the world in R&D spending. Furthermore, increasing demand for advanced and innovative medicines due to increasing prevalence of chronic diseases is driving the growth of the drug discovery market in North America. Asia Pacific is estimated to be the most opportunistic market in the coming years. This can be attributed to the presence of numerous CROs in the region. Moreover, countries such as South Korea, India, and China are investing heavily in the development of the pharmaceutical industry, which is fueling the demand for biopharmaceutical products.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Technologies.
Report Scope
The Drug Discovery Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Discovery Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca
Segment by Type
Small-molecule Drugs
Biologics
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Technologies companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Drug Discovery Technologies 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small-molecule Drugs
1.2.3 Biologics
1.3 麻豆原创 by Application
1.3.1 Global Drug Discovery Technologies 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Technologies 麻豆原创 Perspective (2019-2030)
2.2 Drug Discovery Technologies Growth Trends by Region
2.2.1 Global Drug Discovery Technologies 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Discovery Technologies Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Drug Discovery Technologies Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Drug Discovery Technologies 麻豆原创 Dynamics
2.3.1 Drug Discovery Technologies Industry Trends
2.3.2 Drug Discovery Technologies 麻豆原创 Drivers
2.3.3 Drug Discovery Technologies 麻豆原创 Challenges
2.3.4 Drug Discovery Technologies 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Technologies Players by Revenue
3.1.1 Global Top Drug Discovery Technologies Players by Revenue (2019-2024)
3.1.2 Global Drug Discovery Technologies Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Drug Discovery Technologies 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Technologies Revenue
3.4 Global Drug Discovery Technologies 麻豆原创 Concentration Ratio
3.4.1 Global Drug Discovery Technologies 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Technologies Revenue in 2023
3.5 Drug Discovery Technologies Key Players Head office and Area Served
3.6 Key Players Drug Discovery Technologies Product Solution and Service
3.7 Date of Enter into Drug Discovery Technologies 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Technologies Breakdown Data by Type
4.1 Global Drug Discovery Technologies Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Drug Discovery Technologies Forecasted 麻豆原创 Size by Type (2025-2030)
5 Drug Discovery Technologies Breakdown Data by Application
5.1 Global Drug Discovery Technologies Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Drug Discovery Technologies Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Drug Discovery Technologies 麻豆原创 Size (2019-2030)
6.2 North America Drug Discovery Technologies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Discovery Technologies 麻豆原创 Size by Country (2019-2024)
6.4 North America Drug Discovery Technologies 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Technologies 麻豆原创 Size (2019-2030)
7.2 Europe Drug Discovery Technologies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Discovery Technologies 麻豆原创 Size by Country (2019-2024)
7.4 Europe Drug Discovery Technologies 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Technologies 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Drug Discovery Technologies 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Discovery Technologies 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Drug Discovery Technologies 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Technologies 麻豆原创 Size (2019-2030)
9.2 Latin America Drug Discovery Technologies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Discovery Technologies 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Drug Discovery Technologies 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Technologies 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Drug Discovery Technologies 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Discovery Technologies 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Drug Discovery Technologies 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent
11.1.1 Agilent Company Detail
11.1.2 Agilent Business Overview
11.1.3 Agilent Drug Discovery Technologies Introduction
11.1.4 Agilent Revenue in Drug Discovery Technologies Business (2019-2024)
11.1.5 Agilent Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Drug Discovery Technologies Introduction
11.2.4 GE Healthcare Revenue in Drug Discovery Technologies Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 Albany Molecular Research Inc.
11.3.1 Albany Molecular Research Inc. Company Detail
11.3.2 Albany Molecular Research Inc. Business Overview
11.3.3 Albany Molecular Research Inc. Drug Discovery Technologies Introduction
11.3.4 Albany Molecular Research Inc. Revenue in Drug Discovery Technologies Business (2019-2024)
11.3.5 Albany Molecular Research Inc. Recent Development
11.4 Affymetrix
11.4.1 Affymetrix Company Detail
11.4.2 Affymetrix Business Overview
11.4.3 Affymetrix Drug Discovery Technologies Introduction
11.4.4 Affymetrix Revenue in Drug Discovery Technologies Business (2019-2024)
11.4.5 Affymetrix Recent Development
11.5 Bayer Healthcare
11.5.1 Bayer Healthcare Company Detail
11.5.2 Bayer Healthcare Business Overview
11.5.3 Bayer Healthcare Drug Discovery Technologies Introduction
11.5.4 Bayer Healthcare Revenue in Drug Discovery Technologies Business (2019-2024)
11.5.5 Bayer Healthcare Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Drug Discovery Technologies Introduction
11.6.4 Novartis Revenue in Drug Discovery Technologies Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Drug Discovery Technologies Introduction
11.7.4 AstraZeneca Revenue in Drug Discovery Technologies Business (2019-2024)
11.7.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Agilent
GE Healthcare
Albany Molecular Research Inc.
Affymetrix
Bayer Healthcare
Novartis
AstraZeneca

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.